Skip to main navigation
Logo

Event Details

COSELA™ (trilaciclib) approval conference call

2/16/21 at 8:00 AM EST

Click here for Webcast

Supporting Materials

February 16 2021 Corporate Update 1.4 MB

Tools

Print Page
RSS Feeds
Email Alerts

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock
    • Stock Information
    • Historical Price Lookup
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
  • Resources
    • Committee Composition
    • Management
    • Board of Directors
    • Investor FAQs
  • Contact Us
  • Our Company
    • Our Mission
    • Our Leadership
    • Board of Directors
    • Collaborations
    • Social Responsibility
  • Our Science
    • Pipeline
    • Trilaciclib
    • Rintodestrant
    • Scientific Publications
  • Patients
    • Patient Support
    • G1 Clinical Trials
    • Resources
  • Careers
    • Working at G1
    • Job Opportunities
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
      • Stock Information
      • Historical Lookup
      • Analysts Coverage
    • Financials
      • SEC Filings
      • Annual Reports
    • Resources
      • Committee Composition
      • Management
      • Board of Directors
      • Investor FAQs
    • Contact Us
  • News
  • Medical Professionals
  • Contact
  • Home
  • Our Company
    • Our Mission
    • Our Leadership
    • Board of Directors
    • Collaborations
    • Social Responsibility
  • Our Science
    • Pipeline
    • Trilaciclib
    • Rintodestrant
    • Scientific Publications
  • Patients
    • Patient Support
    • G1 Clinical Trials
    • Resources
  • Careers
    • Working at G1
    • Job Opportunities
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock
      • Stock Information
      • Historical Lookup
      • Analysts Coverage
    • Financials
      • SEC Filings
      • Annual Reports
    • Resources
      • Committee Composition
      • Management
      • Board of Directors
      • Investor FAQs
    • Contact Us
  • News
  • Medical Professionals
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • LinkedIn
  • Twitter
Home © 2019 G1 Therapeutics, Inc. All rights reserved. Website Design: Hane Chow, Inc.
  • LinkedIn
  • Twitter
  • Privacy Policy
  • Cookie Policy
  • Terms of Use